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z.2012.07Abstract Lead represents a signiﬁcant ecological and public health concern due to its toxicity and its
ability to accumulate in living organisms. The present investigation was designated to assess the modu-
lating effect of melatonin (MLT) against lead acetate (LA) genotoxicity. Three cytogenetic end points
were considered: the frequencies of micronucleated polychromatic erythrocyte cells (MnPCEs) in the
bone marrow, the chromosomal aberration in the primary spermatocytes and the frequency of sperm
abnormalities.Male mice were used in this experiment; animals were divided into 8 groups of 6 animals
each. First group received an oral gavage of solvent (4% ethanol) and served as control and the
other groups received an oral gavage ofMLT (10 mg/kg) and/or 10, 50, 100 mg/kg body weight of lead
acetate for 11 days.Mice were scariﬁed 24 h after the last treatment. Examination and analysis ofMnP-
CEs andmeioticmetaphases showednomutagenic effect ofmelatonin.Meanwhile LA induced a signif-
icant (P< 0.01) increase in the three end points used in this investigation. Results showed that
melatonin caused a signiﬁcant reduction in MnPCEs and chromosomal aberrations in meiotic cells.
PCE/NCE ratios in bonemarrowalso increased in relation tomelatonin andLA treatments.Moreover,
melatonin decreased the%of spermabnormality by 28.3%.The dataobtained in this study suggest that
melatonin administration confers protection against damage inﬂicted by LA, and support the conten-
tion thatmelatonin protection is achieved by its ability as a scavenger for free radicals generated by LA.
ª 2012 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. All rights
reserved.Introduction
Melatonin (MLT) is an endogenous molecule produced in the
human and vertebrate pineal gland, the retina and possibly in
some other organs. It is known as the ‘‘hormone of darkness,’’Egyptian German Society for
g by Elsevier
n Society for Zoology. Production
.001and is secreted in darkness in both diurnal and nocturnal ani-
mals (Challet, 2007). Melatonin is a radical scavenger and func-
tions as an antioxidant; it is proven to be a more potent
antioxidant than vitamin E and vitamin A (Korkmaz et al.,
2009). Thus, for its antioxidant potential, MLT has been pro-
posed to use for the protection against molecular damage by
oxygen and nitrogen-based toxic reactants (Reiter et al.,
2004). Synthetic melatonin supplements have been used for a
variety of medical conditions, most notably for disorders re-
lated to sleep (Rajaratnam et al., 2009). In addition, MLT dis-
played a marked role in the protection of testicular toxicity
induced by radiation and different mutagenic and clastogenic
agents (Anjum et al., 2011; Ji et al., 2012).and hosting by Elsevier B.V. All rights reserved.
Table 1 Frequency of micronucleated polychromatic erythrocytes (MnPCEs) and PCE/NCE ratio in mouse bone marrow post
treatment with lead acetate and/or melatonin.
Treatment The frequency of MN PCEs/NCEs
Total MnPCEs/12000PCEs Mean MnPCEs/2000PCEs ±SD Mean ±SD
Control 17 2.83 1.7 0.926 0.12
Melatonin 16 2.67 1.6a 1.03 0.10a
Lead acetate
10 mg/kg bw 39 6.5 1.87b 0.735 0.18a
50 mg/kg bw 135 22.5 1.76c 0.663 0.10c
100 mg/kg bw 129 21.5 1.87d 0.703 0.16b
Melatonin+ Lead acetate
10 mg/kg bw 31 5.16 1.69e 0.835 0.05ns
50 mg/kg bw 110 18.3 2.65f 0.738 0.15ns
100 mg/kg bw 109 18.17 1.94g 0.760 0.14ns
a P> 0.05 compared with control.
b P< 0.05 compared with control.
c P< 0.01 compared with control.
d P< 0.0001 compared with control.
e P> 0.05 compared with 10 mg/kg LA.
f P< 0.01 compared with 50 mg/kg LA.
g P< 0.01 compared with 100 mg/kg LA.
ns P> 0.05 compared with LA.
Table 2 Percentage of the different types of chromosomal aberrations in primary spermatocytes of male mice after treatment with
lead acetate and/or melatonin.
Treatment Examined
metaphases
Time
intervals
Aberrant metaphases Diﬀerent types of chromosomal aberrations
Total Mean % S.D. AU X  Y U AU+ X  YU CIII + I CIV CVI F Pol
Control 600 24 h after 11 days of treatment 26 4.33 1.21 6 4 2 – 8 – – 6
Melatonin 10 mg/kg 600 28 4.67 1.37a 7 5 3 2 7 – – 4
Lead acetate
10 mg/kg bw 600 58 9.67 2.17b 16 10 5 – 17 2 – 8
50 mg/kg bw 600 145 24.17 2.63c 34 17 3 11 39 13 9 19
100 mg/kg bw 600 156 26 2.37c 39 12 15 7 45 12 7 19
Melatonin+
Lead acetate
10 mg/kg bw 600 34 5.67 1.64d 9 6 – – 10 – – 9
50 mg/kg bw 600 116 19.33 2.5e 20 11 – 3 37 16 3 26
100 mg/kg bw 600 136 22.67 2.4f 30 7 12 10 40 18 5 14
AU= autosomal univalent.
X  YU= X  Y univalent.
CIII + I = chain of three plus one.
CIV = chain of four.
CVI = chain of six.
F = fragment.
Pol = Polyploidy.
a P> 0.05 compared with control.
b P< 0.001 compared with control.
c P< 0.0001 compared with control.
d P< 0.01 compared with 10 mg/kg bw LA.
e P< 0.01 compared with 50 mg/kg bw LA.
f P< 0.05 compared with 100 mg/kg bw LA.
224 D.D. Abd El-MonemIn an in vivo and in vitro micronucleus test, MLT signiﬁ-
cantly reduced micronuclei formation in both peripheral blood
and bone marrow cells of lipopolysaccharide treated rats (Sew-
erynek et al., 1996). MLT inhibited the paraquat-induced in-crease in MnPCEs in mice bone marrow cells (Melchiorri
et al., 1998) and in both peripheral blood and bone marrow
cells of mice (Ortiz et al., 2000). MLT also caused a signiﬁcant
reduction in MnPCEs in bone marrow cells of albino mice
Figure 1 The frequency of Mn-PCEs of mice treated with lead acetate and/or melatonin.
Figure 2 Mean percentage of the different types of chromosomal aberrations in primary spermatocytes of male mice after treatment with
lead acetate and/or melatonin.
Figure 3 The percentage of sperm abnormalities induced after lead acetate and/or melatonin treatment.
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226 D.D. Abd El-Monem(Badr et al., 1999); in peripheral blood of rats (Ortega-Gut-
ie´rrez et al., 2009); in peripheral blood and bone marrow cells
of CD2-F1 male mice (Vijayalaxmi et al., 1999) and rats (As-
sayed and Ab-del-aty, 2009) exposed to radiation. In addition,
MLT decreased the frequency of CA and SCEs in human
lymphocytes (Awara et al., 1998) and in spermatogonial and
primary spermatocyte chromosomes of mice exposed to radia-
tion (Badr et al., 1999).
Lead represents a signiﬁcant ecological and public health
concern due to its toxicity and its ability to accumulate in liv-
ing organisms. Earlier studies have demonstrated that lead can
pass through the blood–testis barrier, accumulate in the testis
and/or epididymis and affect the germinal cells at different lev-
els of differentiation (spermatogonia, primary spermatocytes,
spermatids or spermatozoa) (Apostoli et al., 1999). Several
studies assessed the genotoxic effect of lead acetate (LA) by
means of chromosomal aberrations and micronucleus test.
Regarding the induction of chromosomal aberrations, LA in-
duced signiﬁcant increase of aberrant cells and numerical aber-
rations in bone marrow cells of Wistar rats (Lorencz et al.,Figure 4 Micronuclei induced after lead1996; Nehe´z et al., 2000). Additionally, Aboul-Ela (2002) de-
tected a signiﬁcant increase of structural chromosomal aberra-
tions in bone marrow cells and primary spermatocytes of
albino mice treated with LA. In addition, LA proved to be a
potent micronuclei inducer in vivo and in vitro test systems:
LA induced micronuclei in kidney cells of Sprague–Dawley al-
bino rats (Robbiano et al., 1999); in human melanoma cell
(Poma et al., 2003); in Chinese hamster V79 cells (Thier
et al., 2003; Bonacker et al., 2005); in Wistar rats’ leukocytes,
reticulocytes and erythrocytes (Kasˇuba et al., 2004; C¸elik et al.,
2005); in rats’ erythrocytes (Piao et al., 2007; Alghazal et al.,
2008); in peripheral blood erythrocytes, gill and ﬁn epithelial
cells of Carassius auratus auratus (C¸avas, 2008) and in bone
marrow cells of Algerian mice (Tapisso et al., 2009). Moreover,
positive results indicate the induction of SCE with LA was ob-
tained by Poma et al. (2003) in human melanoma cells and in
bone marrow cells of Algerian mice (Tapisso et al., 2009).
The objective of this study is to assess the protective effect
of melatonin to modulate the frequency of lead acetate-in-
duced genotoxicity in male mice.acetate and/or melatonin treatment.
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Animals and treatments
The present study was carried out using 48 adult male mice 9–
12 weeks’ age and 25–30 g in weight which were purchased
from the animal house of The National Research Center,
Cairo, Egypt. Animals were kept in groups of six in different
cages, and acclimatized for 7 days before dosing. Standard lab-
oratory chow and fresh tap water were provided ad libitum.
Mice were divided into 8 groups of 6 animals each. Animals
in the ﬁrst group were given the solvent (4% ethanol) via oral
gavage and served as control. Mice in the other groups re-
ceived oral gavage of 10 mg/kg bw melatonin (Vijayalaxmi
et al., 1999) and or 10, 50 and 100 mg/kg bw lead acetate for
11 days. Mice were sacriﬁced 24 h after the last treatment.Figure 5 Abnormal meiotic metaphases in 1ry spermatChemicals
Lead acetate, also known as lead diacetate, plumbous acetate,
sugar of lead, salt of Saturn, and Goulard’s powder, is a water-
soluble white crystalline chemical compound with a sweetish
taste and was purchased from Sigma–Aldrich, Melatonin (5-
Methoxy-N-acetyltryptamine), and fetal calf serum were pur-
chased from Sigma–Aldrich. Melatonin solution was made
by dissolving 1 mg in 4% ethanol.
Micronucleus test
Both femurs were dissected and bone marrow was ﬂushed
from the femoral cavity with fetal calf serum. The cells were
dispersed by gentle pipetting and collected by centrifugation
at 1000 rpm for 10 min the pellet was resuspended in a smallocytes of male albino mice treated with lead acetate.
228 D.D. Abd El-Monemvolume of fetal calf serum and used for smear preparation.
After air-drying, the smears were stained by Giemsa (Schmid,
1976). From each animal, 2000 PCEs were examined for
micronucleated polychromatic erythrocytes (Mn-PCEs) under
1000 magniﬁcation using light microscope. In addition, the
number of PCEs among 500 total erythrocytes (PCE +NCE)
per animal was recorded to evaluate bone marrow toxicity.
Meiotic preparation and scoring criteria
Mice were sacriﬁced 12 days from the beginning of treatment,
where sample MI cells were at preleptotene at the beginning of
the treatment as recommended by Ciranni and Adler (1991).
Chromosomal preparations were made according to the air-
drying method of Evans et al. (1964). Mice were injected
(i.p.) with colchicines (0.1%) 2 h before killing by cervical dis-
location. The testes were transferred to 2.5 ml of a 2.2% citrate
solution in Petri dishes and the tunica removed. The contents
of the tubules were gently teased out with curved forceps. The
cell suspension produced was aspirated well and centrifuged at
1000 rpm for 10 min the supernatant was discarded, and the
pellet was resuspended in 2 ml of hypotonic solution (1% so-
dium citrate) at 37 C. After 12 min, the suspension was centri-
fuged for 10 min at 1000 rpm. Then the supernatant was
removed. The cells were ﬁxed 3 times with cold ﬁxative solu-
tion (3:1 of methanol and glacial acetic acid). Slides were
stained with Giemsa in phosphate buffer (pH 6.8) for 8 min.
Hundred primary spermatocytes/mouse at diakinesis-meta-
phase I were scored. Abnormalities recorded included univa-
lents (x–y univalent, autosomal univalent), reciprocal
translocations, polyploidy and fragments.
Sperm shape abnormality assay
Evaluation of sperm-shape abnormality was made according
to the technique described by Wyrobek and Bruce (1978).
After the animal was sacriﬁced cauda epididymis was dissectedTable 3 Percentages of abnormal sperms in mice post-treatment w
Treatment Time intervals No of examined
sperms
Types of s
q bh am
Control 24 h after the last treatment 6000 13 17 15
Melatonin
10 mg/kg bw 6000 9 19 17
Lead acetate
10 mg/kg bw 6000 15 27 23
50 mg/kg bw 6000 21 40 38
100 mg/kg bw 6000 18 47 21
Melatonin +
lead acetate
10 mg/kg bw 6000 20 17 21
50 mg/kg bw 6000 25 30 20
100 mg/kg bw 6000 17 39 29
q = quasi-normal, bh = big head, am = amorphous, t = triangular, bs
col = collapsed head, ch = coiled head, wh = without hook, SD = stan
a P> 0.05 compared with control.
b P< 0.001 compared with control.
c P< 0.0001 compared with control
d P< 0.05 compared with10 mg/kg bw LA.
e P< 0.01 compared with 50 mg/kg bw LA.
f P< 0.001 compared with 100 mg/kg bw LA.out and placed in a Petri-plate containing 0.5 ml of saline solu-
tion (0.9% NaCl) at room temperature. The epididymis was
cut into small portions to allow the sperms to swim out. After
that, the smears were prepared using 2–3 drops of the solution,
air dried overnight, ﬁxed with absolute methanol for 15 min
and stained with hematoxylin and eosin. One thousand sperms
per animal were examined to determine the morphological
abnormalities under oil immersion. Sperm shape abnormalities
were classiﬁed as sperm head morphology which was catego-
rized as normal, quasi-normal, amorphous, triangular, col-
lapsed, deformed orientation, acute curvature, coiled head,
banana shape, and without hook and tail abnormality. Data
are shown in terms of % of abnormal sperms.
Statistical analysis
Data from control and treated animals for all tests were ana-
lyzed statistically to assess the signiﬁcant differences using stu-
dent’s t-test.
Results and discussion
Results showed that melatonin had no signiﬁcant effect on the
induction of micronuclei in bone marrow cells and chromo-
somal aberrations in primary spermatocytes which showed
nearly the same values of control as shown in Tables 1 and
2. This indicates that melatonin is neither clastogenic nor
mutagenic and can be used as a protective agent without any
side effects, this observation agrees with Vijayalaxmi et al.
(1995), Musatov et al. (1997) and Badr et al. (1999).
Meanwhile, lead acetate induced signiﬁcant (P< 0.01) in-
creases in bone marrow micronuclei when compared with con-
trol group (Table 1 and Fig. 1). The most frequent types of
micronuclei observed were dot like and round shape (Fig. 4).
The middle dose of LA (50 mg/kg bw) induced the highest
frequency of MnPCEs. In what concerns the polychromatic
to normochromatic ratios, lead acetate (50 and 100 mg/kg)ith lead acetate and/or melatonin.
perm head abnormalities Tail
abnormalities
Total
t bs do ac v-h col c-h wh Total % SD
10 7 – 9 – 8 19 20 19 137 2.28 2.5
17 9 1 11 – 6 19 10 28 146 2.43 3.7a
14 13 – 35 6 11 12 15 21 192 3.2 3.7b
46 42 7 54 16 30 45 25 57 421 7.01 3.7c
61 29 5 35 3 20 36 30 66 371 6.18 4.4c
10 11 1 27 – 8 15 8 27 165 2.75 4.2d
66 29 – 39 – – 49 26 64 348 5.8 6.6e
35 19 – 41 – 10 27 20 29 266 4.43 5.7f
= banana shape, do = deformed orientation, ac = acute curvature,
dard deviation.
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with control, which indicates the toxicity of lead acetate on
bone marrow cells and coincides with Jagetia and Aruna
(1998).
Additionally, the mean percent of primary spermatocyte
chromosomal aberrations in control samples was 4.33. This va-
lue increased after lead acetate treatment into 9.67, 24.17 and
26 (Table 2 and Fig. 2). These highly signiﬁcant (P< 0.01) in-
creases indicate the clastogenic effect of lead acetate. Concern-
ing the types of aberrations, both autosomal and x–y univalent
were observed (Fig. 5). Reciprocal translocations were also de-
tected as trivalent (CIII + I), quadrivalent (chain IV) and
hexavalent (chain VI). Additionally, in few diakinesis-meta-
phases I, cells with fragments were also detected as listed in
Table 2. The above results are in accordance with other studiesFigure 6 Different types of head or tail abnormalities after lead a
curvature, (c) big h, (d) amorphous, (e) hookless, (f) banana shape, (g)
(k) coiled tail and (l) forked tail.using the micronucleus test (Aboul-Ela, 2002; Tapisso et al.,
2009) as well as chromosomal aberration assay in primary
spermatocytes (Aboul-Ela, 2002).
Moreover, a signiﬁcant increase in the % of abnormality in
sperm head morphology was found in animals treated with
lead acetate as compared to control group (Table 3 and
Fig. 3). This result revealed that lead acetate caused clasto-
genic effect which coincides with Aboul-Ela (2002). In addi-
tion, results showed that abnormalities such as acute
curvature, triangular and sperms with big head were the most
frequently observed types after lead exposures (Fig. 6). On the
contrary, the two deformed orientation and vacuolated head
were the least common morphological abnormalities (Table 3).
Several in vitro and in vivo studies have shown that differ-
ent LA metabolic pathways result in ROS generation andcetate and/or melatonin treatment. (a) Quasi-normal, (b) acute
collapsed, (h) triangular, (i) deformed orientation, (j) vacuolated,
230 D.D. Abd El-Monemalteration of antioxidant defense systems in animals (Hsu
et al., 1997; Aykin-Burns et al., 2005; Xu et al., 2008). Halea-
grahara et al. (2011) reported that exposure to lead acetate
caused a marked increase in lipid peroxidation and a reduction
in free radical scavenging enzymes in bone marrow. In the
present investigation, the genotoxic effect of lead acetate in
the three cytogenetic end points used could be due to the
induction of lipid peroxidation and reactive oxygen species
(ROS) which has been considered as one of the direct mecha-
nisms underlying lead-mediated DNA damage (Acharya et al.,
2003). The generation of highly reactive oxygen species (ROS),
such as superoxide radicals ðO2 Þ, hydrogen peroxide (H2O2),
hydroxyl radicals (OH) and lipid peroxides (LPO), in the after-
math of heavy metal ions are known to damage various cellu-
lar components including proteins, membrane lipids and
nucleic acids (Halliwell and Gutteridge, 1989).
Additionally, Monterio et al. (1995) suggested that lead-in-
duced oxidative stress by disrupting the delicate prooxidant/
antioxidant balance exists within mammalian cells. Moreover,
Aitken and Roman (2008) stated that both spermatogenesis
and Leydig cell steroidogenesis are vulnerable to oxidative
stress. In the present investigation, control samples showed
2.28% of abnormal sperms which presumed to be a result of
naturally occurring errors in the differentiation process, or
the consequence of an abnormal chromosome complement.
As well, signiﬁcant increases in the percents of sperm head
abnormalities were detected after lead acetate treatment. These
increases might be due to the effect of lead acetate on the sper-
matogonial cells, Leydig cells and lastly sertoli cells where
sperm maturation takes place (Garu et al., 2011) which results
in an increase of abnormal sperm head deformation. Further-
more, Hsu et al. (1997) and Acharya et al. (2003) declared that
ROS generation causes chromosomal aberrations in germ cells
by mutating certain gene segments involved in the maintenance
of normal sperm structure, resulting in deformed sperm popu-
lation and/or drastically minimizing sperm count.
On the other hand, administration of melatonin, which has
an antioxidant property (Korkmaz et al., 2009) along with lead
acetate markedly hampered lead-induced genotoxicity on the
three cytogenetic end points used in this investigation. Co-
treatment with MLT signiﬁcantly reduced the mean of Mn-
PCEs from 6.5, 22.5 and 21.5 following LA treatment into
5,16, 18.3 and 18.17 and decreased CA% in primary spermat-
ocytes from 9.67, 24.17 and 26 to 5.67, 19.33 and 22.67 (Tables
1 and 2). Also it decreased the sperm abnormality percent by
28.3%. The same results were obtained by other researchers
using radiation or different mutagenic and clastogenic agents
(Sewerynek et al., 1996; Melchiorri et al., 1998; Badr et al.,
1999; Ortiz et al., 2000; Assayed and Ab-del-Aty, 2009).
The anti-genotoxic effect of MLT which appeared in this
investigation might be due to the potent scavenger capacity
of melatonin to both reactive hydroxyl ‘‘OH’’ (Tan et al.,
1993) and peroxyl ‘‘ROO’’ (Pieri et al., 1995) radicals and
the ability of melatonin to increase the concentrations of
endogenous antioxidants such as glutathione (Winiarska
et al., 2006) and to stimulate the antioxidative enzyme glutathi-
one peroxidase (Toma´s-Zapico and Coto-Montes, 2005), lead-
ing to an increase in antioxidant capacity of the cells which
might fortify the efﬁciency of protective pathways against
cytogenetic damage in lead exposure (Ustundag and Duydu,
2007).In conclusion, this study showed that lead acetate has a po-
tent clastogenic effect and melatonin has the ability to evacu-
ate that clastogenic effect as recorded by the percentage of
the abnormalities which retained to control percentages.
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